Author

Christian Haslinger

Boehringer Ingelheim (Germany)Primary ORCID profile (0000-0002-9924-2231 · 2 papers)Unclaimed ORCID profile · follow to get notified of new preprints

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

Christian HaslingeriD2 papers · Boehringer Ingelheim (Austria)

Biology Disciplines

Click to filter author papers

Bioinformatics· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:drug response / drug discovery· 1 Organism:mouse· 1 Approach:statistical model· 1

Frequent Co-Authors

Andre BroermanniD· 1 shared Benjamin StrobeliD· 1 shared Coralie ViolletiD· 1 shared Damian Matera· 1 shared Eric S. SimoniD· 1 shared Francesc Fernández-AlbertiD· 1 shared Heinrich J. HuberiD· 1 shared Holger KleiniD· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBioinformatics

Andre BroermannORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

In Silico Treatment: a computational framework for animal model selection and drug assessment

Sergio Picart‐Armada, Kolja Becker, Marc Kästle, Oliver Krenkel, Eric S. Simon, Stephan P. Tenbaum, Benjamin Strobel, Kerstin E. Geillinger‐Kästle, Katrin Fundel‐Clemens, Damian Matera, Kathleen Lincoln, Jon Hill, Coralie Viollet, Ruediger Streicher, Matthew James Thomas, , Francesc Fernández-Albert

In Silico Treatment evaluates animal models for disease relevance by simulating gene expression changes in humans, identifying suitable models and drug effects.

bioRxiv · Jun 17, 2024 · PreprintBioinformatics